These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6663746)

  • 1. [Blood platelet disorders and thrombotic tendencies associated with Kawasaki disease].
    Yamada K
    Nihon Rinsho; 1983 Sep; 41(9):2097-102. PubMed ID: 6663746
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation abnormalities in Kawasaki disease.
    Yamada K; Shirahata A; Inagaki M
    Prog Clin Biol Res; 1987; 250():239-50. PubMed ID: 3321078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation].
    Shirahata A; Nakamura T; Asakura A
    Nihon Rinsho; 1983 Sep; 41(9):2103-10. PubMed ID: 6663747
    [No Abstract]   [Full Text] [Related]  

  • 4. Kawasaki disease.
    Larson E
    West J Med; 1984 Jun; 140(6):929-30. PubMed ID: 6540009
    [No Abstract]   [Full Text] [Related]  

  • 5. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent.
    Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--].
    Mukaiyama H
    Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
    Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into Platelet Dysfunction in Kawasaki Disease Using a Microfluidic Model of Thrombosis.
    Branchford BR; Neeves K
    J Pediatr; 2020 Nov; 226():10-11. PubMed ID: 32795474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Longitudinal study of platelet function in infantile cortical hyperostosis].
    Esposito L; Carleo R; Guerriero A; Sgambato F; Miano P
    Pediatria (Napoli); 1978 Mar; 86(1):1-13. PubMed ID: 355995
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenetic mechanisms of arteritis in Kawasaki disease--a critical analysis.
    Hansson GK
    Prog Clin Biol Res; 1987; 250():383-94. PubMed ID: 3321080
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reactive thrombocytosis in infants and children (author's transl)].
    Shirahata A; Nojiri T; Yamada K; Meguro T
    Rinsho Ketsueki; 1979 Dec; 20(12):1569-78. PubMed ID: 541845
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coagulation disorders in diabetes mellitus].
    Corsi L; Castellini G; Mignano C; Gherzi R
    Arch Maragliano Patol Clin; 1979; 35(2):133-40. PubMed ID: 400621
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kawasaki disease].
    Kobae H; Miyata K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):315-8. PubMed ID: 11031957
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet dysfunction].
    Terada H
    Nihon Rinsho; 1997 Oct; 55 Suppl():673-80. PubMed ID: 9392180
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet physiology and abnormalities of platelet function (second of two parts).
    Weiss HJ
    N Engl J Med; 1975 Sep; 293(12):580-8. PubMed ID: 1097915
    [No Abstract]   [Full Text] [Related]  

  • 16. Kawasaki disease and the plight of the platelet.
    Corrigan JJ
    Am J Dis Child; 1986 Dec; 140(12):1223-4. PubMed ID: 3776936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G
    Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets in Kawasaki patients: two different populations with different mitochondrial functions.
    Pietraforte D; Gambardella L; Marchesi A; Tarissi de Jacobis I; Villani A; Del Principe D; Malorni W; Straface E
    Int J Cardiol; 2014 Mar; 172(2):526-8. PubMed ID: 24491862
    [No Abstract]   [Full Text] [Related]  

  • 20. Polytetrafluoroethylene-covered stent deployment in the setting of Kawasaki disease.
    Kwon HS; Shin JI; Choi JY; Sul JH; Jang YS
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1075-6; author reply 1077. PubMed ID: 17526008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.